Electrophysiological Characterization of Ts6 and Ts7, K+ Channel Toxins Isolated through an Improved Tityus serrulatus Venom Purification Procedure

In Brazil, Tityus serrulatus (Ts) is the species responsible for most of the scorpion related accidents. Among the Ts toxins, the neurotoxins with action on potassium channels (α-KTx) present high interest, due to their effect in the envenoming process and the ion channel specificity they display. The α-KTx toxins family is the most relevant because its toxins can be used as therapeutic tools for specific target cells. The improved isolation method provided toxins with high resolution, obtaining pure Ts6 and Ts7 in two chromatographic steps. The effects of Ts6 and Ts7 toxins were evaluated in 14 different types of potassium channels using the voltage-clamp technique with two-microelectrodes. Ts6 toxin shows high affinity for Kv1.2, Kv1.3 and Shaker IR, blocking these channels in low concentrations. Moreover, Ts6 blocks the Kv1.3 channel in picomolar concentrations with an IC50 of 0.55 nM and therefore could be of valuable assistance to further designing immunosuppressive therapeutics. Ts7 toxin blocks multiple subtypes channels, showing low selectivity among the channels analyzed. This work also stands out in its attempt to elucidate the residues important for interacting with each channel and, in the near future, to model a desired drug.

[1]  E. Campbell,et al.  Structure of a pore-blocking toxin in complex with a eukaryotic voltage-dependent K+ channel , 2013, eLife.

[2]  Wei Zhang,et al.  Current pharmacogenomic studies on hERG potassium channels. , 2013, Trends in molecular medicine.

[3]  C. Sorgi,et al.  Ts6 and Ts2 from Tityus serrulatus venom induce inflammation by mechanisms dependent on lipid mediators and cytokine production. , 2013, Toxicon : official journal of the International Society on Toxinology.

[4]  D. Mohapatra,et al.  Distinct Modifications in Kv2.1 Channel via Chemokine Receptor CXCR4 Regulate Neuronal Survival-Death Dynamics , 2012, The Journal of Neuroscience.

[5]  Zachary L. Bergeron,et al.  Scorpion Toxins Specific for Potassium (K+) Channels: A Historical Overview of Peptide Bioengineering , 2012, Toxins.

[6]  C. Robbins,et al.  Kv1.1 and Kv1.2: Similar channels, different seizure models , 2012, Epilepsia.

[7]  E. Condom,et al.  Targeting the voltage-dependent K(+) channels Kv1.3 and Kv1.5 as tumor biomarkers for cancer detection and prevention. , 2012, Current medicinal chemistry.

[8]  J. Margolick,et al.  Functional Blockade of the Voltage-gated Potassium Channel Kv1.3 Mediates Reversion of T Effector to Central Memory Lymphocytes through SMAD3/p21cip1 Signaling* , 2011, The Journal of Biological Chemistry.

[9]  H. Wulff,et al.  The lymphocyte potassium channels Kv1.3 and KCa3.1 as targets for immunosuppression , 2011, Drug development research.

[10]  T. Verano-Braga,et al.  From the stretcher to the pharmacy's shelf: drug leads from medically important brazilian venomous arachnid species. , 2011, Inflammation & allergy drug targets.

[11]  S. Grissmer,et al.  Charybdotoxin unbinding from the mKv1.3 potassium channel: a combined computational and experimental study. , 2011, The journal of physical chemistry. B.

[12]  Yingliang Wu,et al.  ImKTx1, a new Kv1.3 channel blocker with a unique primary structure , 2011, Journal of biochemical and molecular toxicology.

[13]  J. Tytgat,et al.  Purification and characterization of Ts15, the first member of a new α-KTX subfamily from the venom of the Brazilian scorpion Tityus serrulatus. , 2011, Toxicon : official journal of the International Society on Toxinology.

[14]  C. Sorgi,et al.  Tityus serrulatus venom and toxins Ts1, Ts2 and Ts6 induce macrophage activation and production of immune mediators. , 2011, Toxicon : official journal of the International Society on Toxinology.

[15]  P. Farrell,et al.  A portable device for the electrical extraction of scorpion venom. , 2011, Toxicon.

[16]  S. Fulton,et al.  Contribution of Kv1.2 Voltage-gated Potassium Channel to D2 Autoreceptor Regulation of Axonal Dopamine Overflow* , 2011, The Journal of Biological Chemistry.

[17]  Yong Zhao,et al.  Molecular Diversity and Functional Evolution of Scorpion Potassium Channel Toxins* , 2010, Molecular & Cellular Proteomics.

[18]  J. Roder,et al.  A New Kv1.2 Channelopathy Underlying Cerebellar Ataxia* , 2010, The Journal of Biological Chemistry.

[19]  M. Nakata,et al.  Voltage-dependent metabolic regulation of Kv2.1 channels in pancreatic beta-cells. , 2010, Biochemical and biophysical research communications.

[20]  P. L. Fletcher,et al.  Vesicle-associated Membrane Protein (VAMP) Cleavage by a New Metalloprotease from the Brazilian Scorpion Tityus serrulatus* , 2009, The Journal of Biological Chemistry.

[21]  Heike Wulff,et al.  Voltage-gated potassium channels as therapeutic targets , 2009, Nature Reviews Drug Discovery.

[22]  A. Soares,et al.  Tityus serrulatus scorpion venom and toxins: an overview. , 2009, Protein and peptide letters.

[23]  Aintzane Alday,et al.  Transient outward potassium channel regulation in healthy and diabetic hearts. , 2009, Canadian journal of physiology and pharmacology.

[24]  J. Tytgat,et al.  A new Kaliotoxin selective towards Kv1.3 and Kv1.2 but not Kv1.1 channels expressed in oocytes. , 2008, Biochemical and biophysical research communications.

[25]  R. C. Rodríguez de la Vega,et al.  A selective blocker of Kv1.2 and Kv1.3 potassium channels from the venom of the scorpion Centruroides suffusus suffusus. , 2008, Biochemical pharmacology.

[26]  J. Tytgat,et al.  A common "hot spot" confers hERG blockade activity to alpha-scorpion toxins affecting K+ channels. , 2008, Biochemical pharmacology.

[27]  T. Verano-Braga,et al.  Tityus serrulatus Hypotensins: a new family of peptides from scorpion venom. , 2008, Biochemical and biophysical research communications.

[28]  J. Tytgat,et al.  OdK2, a Kv1.3 channel-selective toxin from the venom of the Iranian scorpion Odonthobuthus doriae. , 2008, Toxicon : official journal of the International Society on Toxinology.

[29]  Rodrigo Lopez,et al.  Clustal W and Clustal X version 2.0 , 2007, Bioinform..

[30]  Joshua X. Gittelman,et al.  Seizures and reduced life span in mice lacking the potassium channel subunit Kv1.2, but hypoexcitability and enlarged Kv1 currents in auditory neurons. , 2007, Journal of neurophysiology.

[31]  Christine Beeton,et al.  Potassium Channels, Memory T Cells, and Multiple Sclerosis , 2005, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[32]  H. Rüterjans,et al.  Probing the pH‐dependent structural features of α‐KTx12.1, a potassium channel blocker from the scorpion Tityus serrulatus , 2005, Protein science : a publication of the Protein Society.

[33]  P. Calabresi,et al.  Targeting Effector Memory T Cells with a Selective Peptide Inhibitor of Kv1.3 Channels for Therapy of Autoimmune Diseases , 2005, Molecular Pharmacology.

[34]  S. Korn,et al.  Potassium channels , 2005, IEEE Transactions on NanoBioscience.

[35]  M. Delepierre,et al.  Exploring structural features of the interaction between the scorpion toxinCnErg1 and ERG K+ channels , 2004, Proteins.

[36]  M. De Waard,et al.  Toxin determinants required for interaction with voltage-gated K+ channels. , 2004, Toxicon : official journal of the International Society on Toxinology.

[37]  R. C. Rodríguez de la Vega,et al.  Current views on scorpion toxins specific for K+-channels. , 2004, Toxicon : official journal of the International Society on Toxinology.

[38]  M. Delepierre,et al.  The 'functional' dyad of scorpion toxin Pi1 is not itself a prerequisite for toxin binding to the voltage-gated Kv1.2 potassium channels. , 2004, The Biochemical journal.

[39]  O. McManus,et al.  Substitution of a single residue in Stichodactyla helianthus peptide, ShK-Dap22, reveals a novel pharmacological profile. , 2003, Biochemistry.

[40]  E. Arantes,et al.  Tityustoxin‐K(alpha) blockade of the voltage‐gated potassium channel Kv1.3 , 2003, British journal of pharmacology.

[41]  P. Calabresi,et al.  The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS. , 2003, The Journal of clinical investigation.

[42]  G. Caliendo,et al.  Sequence and structure‐activity relationship of a scorpion venom toxin with nitrergic activity in rabbit corpus cavernosum , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[43]  L. Possani,et al.  Disulfide bridges and blockage of Shaker B K(+)-channels by another butantoxin peptide purified from the Argentinean scorpion Tityus trivittatus. , 2003, Toxicon : official journal of the International Society on Toxinology.

[44]  P. Mansuelle,et al.  Covalent structure and some pharmacological features of native and cleaved α‐KTx12−1, a four disulfide‐bridged toxin from Tityus serrulatus venom , 2003, Journal of peptide science : an official publication of the European Peptide Society.

[45]  R. C. Rodríguez de la Vega,et al.  Two novel toxins from the Amazonian scorpion Tityus cambridgei that block Kv1.3 and Shaker B K(+)-channels with distinctly different affinities. , 2002, Biochimica et biophysica acta.

[46]  Gea-Ny Tseng,et al.  Structural and Functional Role of the Extracellular S5-P Linker in the HERG Potassium Channel , 2002, The Journal of general physiology.

[47]  M. Jiang,et al.  Mapping the Binding Site of a Humanether-a-go-go-related Gene-specific Peptide Toxin (ErgTx) to the Channel's Outer Vestibule* , 2002, The Journal of Biological Chemistry.

[48]  S. Sampaio,et al.  A hyaluronidase from Tityus serrulatus scorpion venom: isolation, characterization and inhibition by flavonoids. , 2001, Toxicon : official journal of the International Society on Toxinology.

[49]  D J Weber,et al.  Interaction of a toxin from the scorpion Tityus serrulatus with a cloned K+ channel from squid (sqKv1A). , 2001, Biochemistry.

[50]  Mark J. Miller,et al.  Up-regulation of the IKCa1 Potassium Channel during T-cell Activation , 2000, The Journal of Biological Chemistry.

[51]  M. Corona,et al.  Peptides and genes coding for scorpion toxins that affect ion-channels. , 2000, Biochimie.

[52]  M. De Waard,et al.  Mechanisms of maurotoxin action on Shaker potassium channels. , 2000, Biophysical journal.

[53]  P. L. Fletcher,et al.  NMR solution structure of butantoxin. , 2000, Archives of biochemistry and biophysics.

[54]  G A Gutman,et al.  A unified nomenclature for short-chain peptides isolated from scorpion venoms: alpha-KTx molecular subfamilies. , 1999, Trends in pharmacological sciences.

[55]  M. Delepierre,et al.  Scorpion toxins specific for Na+-channels. , 1999, European journal of biochemistry.

[56]  S. Marangoni,et al.  TsTX-IV, a short chain four-disulfide-bridged neurotoxin from Tityus serrulatus venom which acts on Ca2+-activated K+ channels. , 1999, Toxicon : official journal of the International Society on Toxinology.

[57]  Patrice Gouet,et al.  ESPript: analysis of multiple sequence alignments in PostScript , 1999, Bioinform..

[58]  Stewart‐Tull Toxins , 1998 .

[59]  W. F. Hopkins Toxin and subunit specificity of blocking affinity of three peptide toxins for heteromultimeric, voltage-gated potassium channels expressed in Xenopus oocytes. , 1998, The Journal of pharmacology and experimental therapeutics.

[60]  J. Tytgat,et al.  Effect of fluoxetine on a neuronal, voltage‐dependent potassium channel (Kv1.1) , 1997, British journal of pharmacology.

[61]  O. Pongs,et al.  A four-disulphide-bridged toxin, with high affinity towards voltage-gated K+ channels, isolated from Heterometrus spinnifer (Scorpionidae) venom. , 1997, The Biochemical journal.

[62]  E. Blanc,et al.  Solution structure of TsKapa, a charybdotoxin‐like scorpion toxin from Tityus serrulatus with high affinity for apamin‐sensitive Ca2+‐activated K+ channels , 1997, Proteins.

[63]  N. Sigal,et al.  Blockade of the voltage-gated potassium channel Kv1.3 inhibits immune responses in vivo. , 1997, Journal of immunology.

[64]  H. Rochat,et al.  Maurotoxin, a four disulfide bridge toxin from Scorpio maurus venom: purification, structure and action on potassium channels , 1997, FEBS letters.

[65]  C. Roumestand,et al.  On the Convergent Evolution of Animal Toxins , 1997, The Journal of Biological Chemistry.

[66]  Christopher Miller,et al.  A Strongly Interacting Pair of Residues on the Contact Surface of Charybdotoxin and a Shaker K+ Channel , 1996, Neuron.

[67]  I. Khaytin,et al.  Chemical synthesis and characterization of ShK toxin: a potent potassium channel inhibitor from a sea anemone. , 2009, International journal of peptide and protein research.

[68]  M. Blaustein,et al.  Tityustoxin-Kα, from scorpion venom, blocks voltage-gated, non-inactivating potassium current in cultured central neurons , 1994, Neuropharmacology.

[69]  R. MacKinnon,et al.  Purification and characterization of three inhibitors of voltage-dependent K+ channels from Leiurus quinquestriatus var. hebraeus venom. , 1994, Biochemistry.

[70]  J. H. Collins,et al.  Tityustoxin K alpha blocks voltage-gated noninactivating K+ channels and unblocks inactivating K+ channels blocked by alpha-dendrotoxin in synaptosomes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[71]  E. W. Alves,et al.  Peptide T, a novel bradykinin potentiator isolated from Tityus serrulatus scorpion venom. , 1993, Toxicon : official journal of the International Society on Toxinology.

[72]  M. Rogawski,et al.  Tityustoxin-K alpha, a structurally novel and highly potent K+ channel peptide toxin, interacts with the alpha-dendrotoxin binding site on the cloned Kv1.2 K+ channel. , 1993, Molecular pharmacology.

[73]  N. Sigal,et al.  Voltage-gated potassium channels regulate calcium-dependent pathways involved in human T lymphocyte activation , 1993, The Journal of experimental medicine.

[74]  C. Miller,et al.  A point mutation in a Shaker K+ channel changes its charybdotoxin binding site from low to high affinity. , 1992, Biophysical journal.

[75]  R. MacKinnon,et al.  The aromatic binding site for tetraethylammonium ion on potassium channels , 1992, Neuron.

[76]  M. Blaustein,et al.  Polypeptide toxins from the venoms of Old World and New World scorpions preferentially block different potassium channels. , 1991, Molecular Pharmacology.

[77]  S. Sampaio,et al.  A simplified procedure for the fractionation of Tityus serrulatus venom: isolation and partial characterization of TsTX-IV, a new neurotoxin. , 1989, Toxicon : official journal of the International Society on Toxinology.

[78]  R. MacKinnon,et al.  Charybdotoxin block of Shaker K+ channels suggests that different types of K+ channels share common structural features , 1988, Neuron.

[79]  O. Pongs,et al.  Shaker encodes a family of putative potassium channel proteins in the nervous system of Drosophila. , 1988, The EMBO journal.

[80]  R. MacKinnon,et al.  Charybdotoxin block of single Ca2+-activated K+ channels. Effects of channel gating, voltage, and ionic strength , 1988, The Journal of general physiology.

[81]  R. MacKinnon,et al.  Effects of Channel Gating, Voltage, and Ionic Strength , 1988 .

[82]  Y. Jan,et al.  Cloning of genomic and complementary DNA from Shaker, a putative potassium channel gene from Drosophila. , 1987, Science.

[83]  Y. Jan,et al.  Sequence of a probable potassium channel component encoded at Shaker locus of Drosophila. , 1987, Science.

[84]  Isolation and characterization of toxic proteins from the venom of the Brazilian scorpion Tityus serrulatus. , 1983, Toxicon : official journal of the International Society on Toxinology.

[85]  B. Martin,et al.  Purification and chemical characterization of the major toxins from the venom of the Brazilian scorpion Tityus serrulatus Lutz and Mello , 1981 .

[86]  P. L. Fletcher,et al.  Purification and properties of mammalian toxins from the venom of Brazilian Scorpion Tityus serrulatus Lutz and Mello. , 1977, Archives of biochemistry and biophysics.

[87]  P. Edman,et al.  A protein sequenator. , 1967, European journal of biochemistry.

[88]  C. Diniz,et al.  Separation of toxic components from the brazillian scorpion Tityus serrulatus venom. , 1966, Memorias do Instituto Butantan.

[89]  O DE MAGALHAES Scorpion , 1947, Revista brasileira de medicina.